abstract |
Use of a compound of Formula (I) or a pharmaceutically acceptable salt, prodrug, or a metabolite thereof is disclosed herein, where Y, A, and B are as described herein, for use as medicaments in the treatment of the inflammatory bowel disease or glaucoma. Some compounds of Formula (I) are new. |